TransMedics Group, Inc.
NASDAQ:TMDX
74.57 (USD) • At close February 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 394.812 | 201.182 | 25.58 | 24.581 | 20.092 | 20.241 | 11.936 | 9.837 |
| Short Term Investments
| 0 | 0 | 66.872 | 101.061 | 60.596 | 0 | 12.727 | 38.001 |
| Cash and Short Term Investments
| 394.812 | 201.182 | 92.452 | 125.642 | 80.688 | 20.241 | 24.663 | 47.838 |
| Net Receivables
| 63.576 | 27.611 | 5.934 | 6.864 | 6.559 | 3.438 | 0.925 | 1.379 |
| Inventory
| 44.235 | 20.605 | 14.859 | 11.934 | 11.216 | 9.277 | 7.971 | 6.335 |
| Other Current Assets
| 8.031 | 2.896 | 10.92 | 4.652 | 3.076 | 1.838 | 0.477 | 0.311 |
| Total Current Assets
| 510.654 | 252.294 | 118.705 | 146.766 | 100.001 | 34.794 | 34.036 | 55.863 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 180.487 | 24.353 | 15.688 | 4.754 | 4.792 | 3.474 | 2.459 | 1.723 |
| Goodwill
| 11.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 2.354 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 14.344 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.562 | 0 | 0 | 0.006 | 0.006 | 3.389 | 0.006 | 0.518 |
| Total Non-Current Assets
| 195.393 | 24.853 | 16.188 | 5.26 | 5.298 | 7.363 | 2.965 | 2.241 |
| Total Assets
| 706.047 | 277.147 | 134.893 | 152.026 | 105.299 | 42.157 | 37.001 | 58.104 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 12.717 | 3.341 | 6.651 | 1.206 | 7.247 | 4.72 | 3.515 | 4.25 |
| Short Term Debt
| 2.035 | 2.888 | 0 | 0 | 0 | 0 | 1.805 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 1.961 | 0.241 | 0.25 | 0.263 | 0.166 | 0.306 | 0.239 | 0 |
| Other Current Liabilities
| 38.221 | 17.191 | 16.337 | 10.41 | 8.702 | 7.833 | 5.579 | 5.221 |
| Total Current Liabilities
| 54.934 | 23.661 | 23.238 | 11.879 | 16.115 | 12.553 | 10.899 | 9.471 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 513.911 | 66.111 | 43.801 | 34.657 | 34.146 | 33.67 | 6.847 | 8.407 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0.759 | 1.107 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | -0.759 | -1.107 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 1.599 | 0.389 | 0.759 | 187.979 | 1.437 |
| Total Non-Current Liabilities
| 513.911 | 66.111 | 43.801 | 36.256 | 34.535 | 34.429 | 194.826 | 9.844 |
| Total Liabilities
| 568.845 | 89.772 | 67.039 | 48.135 | 50.65 | 46.982 | 205.725 | 19.315 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 105.299 | 186.519 | 186.519 | 187.031 |
| Common Stock
| 641.106 | 666.277 | 510.488 | 502.217 | 424.134 | 331.212 | 0.001 | 0.001 |
| Retained Earnings
| -503.705 | -478.677 | -442.446 | -398.231 | -369.483 | -335.936 | -312.18 | -291.357 |
| Accumulated Other Comprehensive Income/Loss
| -0.199 | -0.225 | -0.188 | -0.095 | -0.002 | -0.101 | -0.149 | -0.417 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 144.692 | 143.604 | 143.531 |
| Total Shareholders Equity
| 137.202 | 187.375 | 67.854 | 103.891 | 54.649 | -4.825 | -168.724 | 38.789 |
| Total Equity
| 137.202 | 187.375 | 67.854 | 103.891 | 54.649 | -4.825 | -168.724 | 38.789 |
| Total Liabilities & Shareholders Equity
| 706.047 | 277.147 | 134.893 | 152.026 | 105.299 | 42.157 | 37.001 | 58.104 |